These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16184836)

  • 41. Autoreactivity in patients with Behçet's disease.
    Taylor PV; Chamberlain MA; Scott JS
    Br J Rheumatol; 1993 Oct; 32(10):908-10. PubMed ID: 7691368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach.
    Hu CJ; Pan JB; Song G; Wen XT; Wu ZY; Chen S; Mo WX; Zhang FC; Qian J; Zhu H; Li YZ
    Mol Cell Proteomics; 2017 Feb; 16(2):147-156. PubMed ID: 27777341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.
    Bassyouni IH; Gamal S; Talaat RM; Siam I
    Mod Rheumatol; 2013 Apr; ():. PubMed ID: 23564409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
    Cervera R; Navarro M; López-Soto A; Cid MC; Font J; Esparza J; Reverter JC; Monteagudo J; Ingelmo M; Urbano-Márquez A
    Ann Rheum Dis; 1994 Apr; 53(4):265-7. PubMed ID: 8203957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmunity to S-antigen and retinal vasculitis in patients with Behçet's disease.
    Ermakova NA; Alekberova ZS; Prokaeva TB
    Adv Exp Med Biol; 2003; 528():279-81. PubMed ID: 12918707
    [No Abstract]   [Full Text] [Related]  

  • 46. The anti-ribosomal P antibodies and prognosis in autoimmune hepatitis.
    Calich AL; Bonfa E
    Liver Int; 2014 Feb; 34(2):324. PubMed ID: 24119250
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis.
    Muratori L; Masi C; Muratori P
    Liver Int; 2014 Oct; 34(9):1446. PubMed ID: 24807202
    [No Abstract]   [Full Text] [Related]  

  • 48. Activation markers in Behçet's disease.
    Coskun B; Saral Y; Gödekmerdan A; Erden I; Coskun N
    Skinmed; 2005; 4(5):282-6. PubMed ID: 16282749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestations.
    Hamzaoui K; Hamzaoui A; Bouajina L; Houman H
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S49-52. PubMed ID: 16273764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.
    Giansanti F; Barbera ML; Virgili L; Pieri B; Emmi L; Menchini U
    Eur J Ophthalmol; 2004 Sep - Oct 2004; 14(5):445-448. PubMed ID: 28221491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
    Ricart JM; Vayá A; Todolí J; Santaolaria ML; Calvo J; Aznar J
    Clin Hemorheol Microcirc; 2005; 33(4):389-96. PubMed ID: 16317248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary 8-isoprostaglandin F(2alpha) level in Behçet's disease.
    Ozdöl NC; Ateş A; Aydintuğ OT; Melli M
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):96-106. PubMed ID: 16303608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.
    Ozkul Y; Evereklioglu C; Borlu M; Taheri S; Calis M; Dündar M; Ilhan O
    Br J Ophthalmol; 2005 Dec; 89(12):1634-7. PubMed ID: 16299146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet's disease.
    Uzunoğlu S; Acar H; Okudan N; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Jan; 297(7):289-93. PubMed ID: 16283344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome.
    Gogus F; Fresko I; Elbir Y; Eksioglu-Demiralp E; Direskeneli H
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S81-5. PubMed ID: 16273771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome.
    Fresko I; Ugurlu S; Ozbakir F; Celik A; Yurdakul S; Hamuryudan V; Yazici H
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S67-70. PubMed ID: 16273768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship?
    Espinosa G; Arostegui JI; Plaza S; Rius J; Cervera R; Yagüe J; Font J
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S64-6. PubMed ID: 16273767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease.
    Jang WC; Park SB; Nam YH; Lee SS; Kim JW; Chang IS; Kim KT; Chang HK
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S59-63. PubMed ID: 16273766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrinolytic activity and d-dimer levels in Behçet's syndrome.
    Yurdakul S; Hekim N; Soysal T; Fresko I; Bavunoglu I; Ozbakir F; Tabak F; Melikoglu M; Hamuryudan V; Yazici H
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S53-8. PubMed ID: 16273765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.